Dr. Cheryl Gregory-Evans' New Publication Advances Amyotrophic Lateral Sclerosis (ALS) Research
Dr. Cheryl Gregory-Evans' New Publication Advances Amyotrophic Lateral Sclerosis (ALS) Research
May 14, 2023
Congratulations to Dr. Cheryl Gregory-Evans on her latest publication, "Levamisole Derivatives as Immune Modulators for the Treatment of Amyotrophic Lateral Sclerosis (ALS)" in Future Medicinal Chemistry. Dr Gregory-Evans and her team have discovered a number of interesting derivatives that have encouraging cytokine response data and good metabolic stability, with the potential to have a positive impact on ALS either as single agents, or in combination.